Lumosa Therapeutics Co., Ltd. (TPEX:6535)
151.00
-1.00 (-0.66%)
Mar 13, 2026, 1:30 PM CST
-25.43% (1Y)
| Market Cap | 25.29B -39.1% |
| Revenue (ttm) | 35.83M -8.5% |
| Net Income | -340.54M |
| EPS | -2.05 |
| Shares Out | 167.49M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 117,366 |
| Average Volume | 253,023 |
| Open | 150.00 |
| Previous Close | 152.00 |
| Day's Range | 149.50 - 153.00 |
| 52-Week Range | 122.00 - 329.50 |
| Beta | 0.02 |
| RSI | 33.14 |
| Earnings Date | May 11, 2026 |